Single answer
Is Arvinas Inc (ARVN) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
What is the conclusion?
Right now our advanced algorithms say:
$1 invested is now $0.80 or -19.53%
(In 42 weeks 6 days 4 hours 21 minutes and 13 seconds .)
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Arvinas Inc is $13.60, which is $1.622 (13.54%) above the current price today's price.
Low target: $6.00 | High target: $18.00
Company snapshot
A quick overview of the business and its public profile.
Arvinas Inc a clinicalstage biopharmaceutical company engages in the discovery development and commercialization of therapies to degrade diseasecausing proteins Its lead product candidates include Bavdegalutamide a proteolysis targeting chimera PROTAC protein degrader that is in phase I clinical trial targeting the androgen receptor AR protein for the treatment of men with metastatic castrationresistant prostate cancer mCRPC ARV471 a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positiveHER2 negative breast cancer and ARV766 an investigational orally bioavailable PROTAC protein degrader for the treatment of men with mCRPC The company has collaborations with Pfizer Inc Genentech Inc F HoffmanLa Roche Ltd and Bayer AG Arvinas Inc was founded in 2013 and is based in New Haven Connecticut
Website: https://www.arvinas.com
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.01. Cash flow to debt ratio: -35.22. Net profit margin: -18.73%. Inflation risk score: medium (0.60/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Arvinas Inc is $19.5M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
We cannot find data for Arvinas Inc 10 years ago, but if you had invested on 2018-09-27 when the price was $16.05, you would have made a loss of $4.32 per share or 26.92%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.